Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Operating Expenses (2010 - 2026)

Lite Strategy (LITS) posted Operating Expenses of $21.6 million for Q1 2026, down 27.65% on a QoQ basis from $29.9 million in Q4 2025, and up 679.02% year-over-year from $2.8 million in Q1 2025.

Analysis

Lite Strategy (LITS) Operating Expenses (2010 - 2026) Analysis & Trends

Lite Strategy has reported Operating Expenses for 17 years, with the latest figure at $21.6 million in Q1 2026.

  • On a quarterly basis, Operating Expenses rose 679.02% year-over-year to $21.6 million in Q1 2026; TTM through Mar 2026 was $58.1 million, a 73.12% increase from a year earlier, with the FY2025 full-year figure at $17.5 million, down 65.61% from the prior year.
  • Operating Expenses was $21.6 million for Q1 2026 at Lite Strategy, down from $29.9 million in the prior quarter.
  • The five-year high for Operating Expenses was $31.3 million in Q1 2022, with the low at $2.8 million in Q1 2025.
  • Average Operating Expenses over 5 years is $15.8 million, with a median of $12.5 million recorded in 2023.
  • The largest YoY upside for Operating Expenses was 765.46% in 2025 against a maximum downside of 84.84% in 2025.
  • Over 5 years, Operating Expenses stood at $23.8 million in 2022, then tumbled by 49.89% to $11.9 million in 2023, then plunged by 71.07% to $3.5 million in 2024, then surged by 765.46% to $29.9 million in 2025, then slipped by 27.65% to $21.6 million in 2026.
  • The last three Operating Expenses figures came in at $21.6 million (Q1 2026), $29.9 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.05 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 367.83 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn - 21.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 21.61 Mn
Dec 31, 2025 29.87 Mn
Sep 30, 2025 3.74 Mn
Jun 30, 2025 2.88 Mn
Mar 31, 2025 2.77 Mn
Dec 31, 2024 3.45 Mn
Sep 30, 2024 8.35 Mn
Jun 30, 2024 18.98 Mn
Mar 31, 2024 9.83 Mn
Dec 31, 2023 11.93 Mn
Sep 30, 2023 10.02 Mn
Jun 30, 2023 12.54 Mn
Mar 31, 2023 22.29 Mn
Dec 31, 2022 23.81 Mn
Sep 30, 2022 26.95 Mn
Jun 30, 2022 27.61 Mn
Mar 31, 2022 31.25 Mn
Dec 31, 2021 29.46 Mn
Sep 30, 2021 27.86 Mn
Jun 30, 2021 22.93 Mn